BioSpace News Archive

Admiral Kirkland “Kirk” Donald, U.S. Navy and member of Battelle’s Board of Directors since 2015, was elected Chairman of the Battelle Board, effective immediately.

Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – today reported financial results for its third quarter ended September 30, 2022 and provided a corporate update.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences.

Natera, Inc. (Nasdaq: NTRA) (“Natera”), a global leader in cell-free DNA testing, today announced the launch of a proposed follow-on public offering of $350,000,000 of shares of its common stock.

ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing services announced today that it expects to release financial results for the third quarter of 2022 before the market open Monday, November 28, 2022.

Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application of ASC10 for monkeypox indication.

YS Biopharma Co., Ltd. (“YS Biopharma” or the “Company”) today announced that its manufacturing facility for PIKA recombinant COVID-19 vaccine successfully passed an audit by a European Union (“EU”) Qualified Person (“QP”) and received QP declaration of its GMP equivalence to European Union Good Manufacturing Practice (“EU GMP”).

BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended September 30, 2022.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, Chief Executive Officer, will participate at the 13th Annual Craig-Hallum Alpha Select Conference on Thursday, November 17th.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on Tuesday, November 29, 2022 at 8:00 am Eastern Time.